Results 91 to 100 of about 68,702 (192)
Mutations in BRCA2 and taxane resistance in prostate cancer
Mutations in BRCA1 or BRCA2 define a subset of prostate cancer patients. Herein, we address the question whether BRCA1/2 mutations have a predictive impact on chemotherapy with docetaxel, a widely used drug in patients with metastatic castration ...
Cathleen Nientiedt +13 more
doaj +1 more source
The circadian clock component PER2 coordinates daily oscillations in gene expression across multiple tissues, yet its role in assembling multi-protein regulatory complexes remains incompletely understood.
Elizaveta Kadukhina +7 more
doaj +1 more source
Molecular docking analysis of the BRCA1 protein with compounds from Justica adhatoda L. [PDF]
Jayaraman S +7 more
europepmc +1 more source
Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study. [PDF]
Hussein IA +6 more
europepmc +1 more source
Background Breast cancer is one of the major global health concerns, and the investigation of mutations in the BRCA1 gene is essential for prevention and treatment. Carriers of pathogenic BRCA1 gene variants face an increased risk of breast cancer during
Masoumeh Jangjou +3 more
doaj +1 more source
Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation. [PDF]
Kim S, Jin H, Seo HR, Lee HJ, Lee YS.
europepmc +1 more source
BRCA1-Associated Protein 1 Testing in Cancer [PDF]
openaire +2 more sources
Non canonical BRCA1 promotes cell survival via modulating PARP13-mediated SEC61G mRNA decay
BRCA1, a well-known tumor suppressor, maintains genomic integrity by facilitating homologous recombination (HR) repair and protecting DNA replication forks. However, its roles beyond DNA repair and replication remain largely unexplored.
Binghe Sun +8 more
doaj +1 more source

